SQZ Biotechnologies Co·4

Oct 30, 6:30 PM ET

BERNSTEIN HOWARD PHD MD 4

4 · SQZ Biotechnologies Co · Filed Oct 30, 2020

Insider Transaction Report

Form 4
Period: 2020-10-29
BERNSTEIN HOWARD PHD MD
Chief Scientific Officer
Transactions
  • Award

    Stock Option

    2020-10-29+10,53010,530 total
    Exercise: $16.00Exp: 2030-10-28Common Stock (10,530 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable as to 25% of the underlying shares on October 29, 2021 and in 36 equal monthly installments thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION